骨髓纤维化相关的外骨髓质造血:对肝,肺和血栓并发症的洞察
Idoroenyi Amanam1, Salman Otoukesh1, Vinod Pullarkat1
1Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States of America.
Blood reviews
|December 4, 2025
概括
在接受干细胞移植的原发性骨髓纤维化 (PMF) 患者中,外骨髓造血 (EMH) 并发症是显著的,但可能是可逆的. 多学科的方法和治疗的进步提供了更好的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 原发性骨髓纤维化 (PMF) 是一种侵袭性的费城染色体阴性骨髓扩散性瘤.
- PMF的特点是髓纤维化,无效的血液形成和炎症,导致外骨髓血液形成 (EMH).
- EMH增加了肝脏,肺和血栓并发症的风险,特别是在接受全源造血干细胞移植 (allo-HCT) 的患者中.
研究的目的:
- 审查PMF中EMH相关并发症的病理生理学,临床表现和管理.
- 通过整合机构经验和当前文献,优化接受alo-HCT的PMF患者的治疗结果.
- 为了解决与EMH相关的肝,肺和血管并发症提供见解.
主要方法:
- 综合了关于肌肉扩散性瘤 (MPNs) 中EMH的当前文献.
- 关于肝门高血压,肺高血压和静脉血栓的综合当代数据.
- 突出了欧洲血液和骨髓移植学会 (EBMT) 注册数据和机构观察的关键见解.
主要成果:
- 门性高血压影响3-18%的MPN患者,由阴侧透,脏高动力循环和血栓形成驱动.
- 脊柱静脉血栓症可以在MPN诊断之前;经常检测到JAK2V617F.
- 肺部并发症,包括EMH和肺高血压,对移植后的非复发性死亡率有显著的贡献.
- 卢克索利提尼布,低强度调节和面向脏的策略改善了接受allo-HCT的PMF患者的治疗结果.
结论:
- 与EMH相关的并发症是生物活跃的,但在疾病控制下可能是可逆的.
- 根据疾病生物学和移植考虑量身定制的多学科方法对于PMF中管理EMH至关重要.
- 细胞因子调节,调节和抗纤维素剂的进步显示出改善患者结果的希望.
相关概念视频
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Pulmonary Embolism I: Introduction
471
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
471
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Pulmonary Tuberculosis III
899
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
899
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203


